产品说明
生化/生理作用
Valrubicin is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin. Valrubicin is converted intracytoplasmically into N-trifluoroacetyladriamycin, which interacts with topoisomerase II, stabilizing the complex between the enzyme and DNA and causing cell cycle arrest.
基本信息
| 经验(实验)分子式 | C34H36F3NO13 |
| 分子量 | 723.64 |
产品性质
| 形式 | powder or crystals |
| 储存温度 | 2-8℃ |
| InChI | 1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14?,17?,19-,22?,27?,33-/m0/s1 |
| InChI key | ZOCKGBMQLCSHFP-ZQUOIQDWSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Danger |
| 危险声明 | H302 - H340 - H350 - H360F |
| 预防措施声明 | P201 - P202 - P264 - P280 - P301 + P312 + P330 - P308 + P313 |
| 危险分类 | Acute Tox. 4 Oral - Carc. 1B - Muta. 1B - Repr. 1B |
| 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
m.cnreagent.com
